FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5                       
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

MURPHY ANDREW J
2. Issuer Name and Ticker or Trading Symbol

REGENERON PHARMACEUTICALS, INC. [ REGN ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                    _____ 10% Owner
__X__ Officer (give title below)    _____ Other (specify below)
EVP Research
(Last)          (First)          (Middle)

777 OLD SAW MILL RIVER ROAD
3. Date of Earliest Transaction (MM/DD/YYYY)

7/13/2020
(Street)

TARRYTOWN, NY 10591
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 7/13/2020  S(1)  96 D$620.64 (2)49855 D  
Common Stock 7/13/2020  S(1)  81 D$621.98 49774 D  
Common Stock 7/13/2020  S(1)  333 D$622.74 (3)49441 D  
Common Stock 7/13/2020  S(1)  740 D$623.66 (4)48701 D  
Common Stock 7/13/2020  S(1)  370 D$624.47 (5)48331 D  
Common Stock 7/13/2020  S(1)  173 D$625.86 (6)48158 D  
Common Stock 7/13/2020  S(1)  1003 D$626.63 (7)47155 D  
Common Stock 7/13/2020  S(1)  657 D$627.54 (8)46498 D  
Common Stock 7/13/2020  S(1)  259 D$628.32 (9)46239 D  
Common Stock 7/13/2020  S(1)  883 D$629.62 (10)45356 D  
Common Stock 7/13/2020  S(1)  1423 D$630.5 (11)43933 D  
Common Stock 7/13/2020  S(1)  861 D$631.45 (12)43072 D  
Common Stock 7/13/2020  S(1)  680 D$632.65 (13)42392 D  
Common Stock 7/13/2020  S(1)  441 D$633.28 (14)41951 D  
Common Stock 7/13/2020  M(1)  13000 A$30.63 54951 D  
Common Stock 7/13/2020  F(1)  6691 D$623.98 48260 D  
Common Stock 7/14/2020  S(1)  178 D$614.62 (15)48082 D  
Common Stock 7/14/2020  S(1)  203 D$615.59 (16)47879 D  
Common Stock 7/14/2020  S(1)  256 D$616.34 (17)47623 D  
Common Stock 7/14/2020  S(1)  304 D$617.64 (18)47319 D  
Common Stock 7/14/2020  S(1)  255 D$618.39 (19)47064 D  
Common Stock 7/14/2020  S(1)  162 D$619.28 (20)46902 D  
Common Stock 7/14/2020  S(1)  81 D$620.94 (21)46821 D  
Common Stock 7/14/2020  S(1)  113 D$621.06 46708 D  
Common Stock 7/14/2020  S(1)  1 D$622.51 46707 D  
Common Stock 7/14/2020  S(1)  487 D$624.77 (22)46220 D  
Common Stock 7/14/2020  S(1)  4 D$625.05 46216 D  
Common Stock 7/14/2020  S(1)  83 D$626.66 46133 D  
Common Stock 7/14/2020  S(1)  950 D$628.5 (23)45183 D  
Common Stock 7/14/2020  S(1)  852 D$629.58 (24)44331 (25)D  

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security3. Trans. Date3A. Deemed Execution Date, if any4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares

Explanation of Responses:
(1) Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
(2) Represents volume-weighted average price of sales of 96 shares of Company stock on July 13, 2020 at prices ranging from $620.64 to $620.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 13, 2020 at each separate price.
(3) Represents volume-weighted average price of sales of 333 shares of Company stock on July 13, 2020 at prices ranging from $622.46 to $622.84. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 13, 2020 at each separate price.
(4) Represents volume-weighted average price of sales of 740 shares of Company stock on July 13, 2020 at prices ranging from $623.01 to $623.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 13, 2020 at each separate price.
(5) Represents volume-weighted average price of sales of 370 shares of Company stock on July 13, 2020 at prices ranging from $624.08 to $624.77. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 13, 2020 at each separate price.
(6) Represents volume-weighted average price of sales of 173 shares of Company stock on July 13, 2020 at prices ranging from $625.77 to $625.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 13, 2020 at each separate price.
(7) Represents volume-weighted average price of sales of 1,003 shares of Company stock on July 13, 2020 at prices ranging from $626.03 to $626.88. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 13, 2020 at each separate price.
(8) Represents volume-weighted average price of sales of 657 shares of Company stock on July 13, 2020 at prices ranging from $627.00 to $627.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 13, 2020 at each separate price.
(9) Represents volume-weighted average price of sales of 259 shares of Company stock on July 13, 2020 at prices ranging from $628.20 to $628.57. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 13, 2020 at each separate price.
(10) Represents volume-weighted average price of sales of 883 shares of Company stock on July 13, 2020 at prices ranging from $629.05 to $629.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 13, 2020 at each separate price.
(11) Represents volume-weighted average price of sales of 1,423 shares of Company stock on July 13, 2020 at prices ranging from $630.06 to $630.83. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 13, 2020 at each separate price.
(12) Represents volume-weighted average price of sales of 861 shares of Company stock on July 13, 2020 at prices ranging from $631.06 to $631.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 13, 2020 at each separate price.
(13) Represents volume-weighted average price of sales of 680 shares of Company stock on July 13, 2020 at prices ranging from $632.02 to $632.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 13, 2020 at each separate price.
(14) Represents volume-weighted average price of sales of 441 shares of Company stock on July 13, 2020 at prices ranging from $633.25 to $633.29. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 13, 2020 at each separate price.
(15) Represents volume-weighted average price of sales of 178 shares of Company stock on July 14, 2020 at prices ranging from $614.41 to $614.84. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 14, 2020 at each separate price.
(16) Represents volume-weighted average price of sales of 203 shares of Company stock on July 14, 2020 at prices ranging from $615.58 to $615.59. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 14, 2020 at each separate price.
(17) Represents volume-weighted average price of sales of 256 shares of Company stock on July 14, 2020 at prices ranging from $616.05 to $616.85. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 14, 2020 at each separate price.
(18) Represents volume-weighted average price of sales of 304 shares of Company stock on July 14, 2020 at prices ranging from $617.34 to $617.86. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 14, 2020 at each separate price.
(19) Represents volume-weighted average price of sales of 255 shares of Company stock on July 14, 2020 at prices ranging from $618.17 to $618.55. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 14, 2020 at each separate price.
(20) Represents volume-weighted average price of sales of 162 shares of Company stock on July 14, 2020 at prices ranging from $619.01 to $619.54. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 14, 2020 at each separate price.
(21) Represents volume-weighted average price of sales of 81 shares of Company stock on July 14, 2020 at prices ranging from $620.07 to $620.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 14, 2020 at each separate price.
(22) Represents volume-weighted average price of sales of 487 shares of Company stock on July 14, 2020 at prices ranging from $624.38 to $624.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 14, 2020 at each separate price.
(23) Represents volume-weighted average price of sales of 950 shares of Company stock on July 14, 2020 at prices ranging from $628.03 to $628.88. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 14, 2020 at each separate price.
(24) Represents volume-weighted average price of sales of 852 shares of Company stock on July 14, 2020 at prices ranging from $629.22 to $629.84. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 14, 2020 at each separate price.
(25) Form one of two

Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
MURPHY ANDREW J
777 OLD SAW MILL RIVER ROAD
TARRYTOWN, NY 10591


EVP Research

Signatures
/s/**Andrew Murphy7/14/2020
**Signature of Reporting PersonDate

Regeneron Pharmaceuticals (NASDAQ:REGN)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Regeneron Pharmaceuticals Charts.
Regeneron Pharmaceuticals (NASDAQ:REGN)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Regeneron Pharmaceuticals Charts.